Canna-V-Cell Sciences (CNVCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CNVCF | AMGN | VRTX | REGN | GILD |
| Company | Canna-V-Cell Sciences | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1800 | 313.34 | 467.94 | 1,047.11 | 68.63 |
| High | 0.1867 | 319.00 | 478.96 | 1,069.69 | 69.99 |
| Low | 0.1650 | 310.23 | 467.86 | 1,045.00 | 68.50 |
| Last | 0.1867 | 311.14 | 471.24 | 1,057.30 | 68.68 |
| Change | +0.0067 | -1.31 | +2.52 | +6.27 | +0.07 |
| % Change | +3.72% | -0.42% | +0.54% | +0.60% | +0.10% |
| Volume | 183,300 | 987,599 | 631,838 | 265,559 | 3,710,844 |
| 20-Day Average Volume | 61,560 | 2,437,411 | 1,320,233 | 478,540 | 9,431,438 |
| Previous Close | 0.1800 | 312.45 | 468.72 | 1,051.03 | 68.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1823 | 307.55 | 475.68 | 1,031.92 | 66.27 |
| 20-Day Raw Stochastic | 62.00% | 50.37% | 54.08% | 74.12% | 62.93% |
| 20-Day Relative Strength | 51.34% | 55.92% | 59.30% | 65.92% | 55.50% |
| Weighted Alpha | +14.23 | +36.39 | +40.74 | +49.34 | -9.94 |
| Today's Opinion | 64% Buy | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 48% Buy | 100% Buy | 88% Buy | 100% Buy | 56% Sell |
| Last Month's Opinion | 64% Buy | 72% Buy | 88% Buy | 72% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.72% since 05/23/24 | -2.30% since 06/24/24 | -0.75% since 06/24/24 | -0.85% since 06/24/24 | -2.93% since 06/24/24 |
| Low | 0.1650 on 05/31/24 | 310.23 on 07/01/24 | 467.67 on 06/28/24 | 1,041.78 on 06/28/24 | 68.06 on 06/28/24 |
| High | 0.1950 on 05/30/24 | 326.12 on 06/25/24 | 483.92 on 06/25/24 | 1,081.17 on 06/25/24 | 71.48 on 06/25/24 |
| 1-Month | |||||
| %Chg | +9.82% since 04/30/24 | +1.63% since 05/31/24 | +3.53% since 05/31/24 | +7.62% since 05/31/24 | +6.83% since 05/31/24 |
| Low | 0.1650 on 05/31/24 | 295.30 on 06/13/24 | 453.73 on 06/03/24 | 979.26 on 06/03/24 | 62.69 on 06/18/24 |
| High | 0.2000 on 05/20/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | +10.67% since 02/29/24 | +9.82% since 04/01/24 | +12.11% since 04/01/24 | +8.82% since 04/01/24 | -5.79% since 04/01/24 |
| Low | 0.1539 on 03/08/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 0.2200 on 03/21/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.85 on 04/02/24 |
| 6-Month | |||||
| %Chg | +47.94% since 11/29/23 | +7.92% since 12/29/23 | +15.86% since 12/29/23 | +20.10% since 12/29/23 | -15.25% since 12/29/23 |
| Low | 0.1328 on 12/04/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 871.39 on 01/02/24 | 62.07 on 05/31/24 |
| High | 0.2200 on 03/21/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 107,330 | 167,609,120 | 120,954,608 | 115,808,784 | 85,477,984 |
| Shares Outstanding, K | 574,878 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 12,670,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -12,560,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 4,520,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -7,240,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | N/A | 0.60 | 0.41 | 0.13 | 0.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 04/30/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 04/02/24 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.84 | 31.38 | 28.32 | 17.08 |